Libby Baney Quoted by World Trademark Review on Proposed DRUGS Act

World Trademark Review turned to government and regulatory affairs partner Libby Baney for insight on the Domain Reform for Unlawful Drug Sellers (DRUGS) Act that was recently introduced in the U.S. Senate. The bill would provide a process for locking and suspending domain names used to facilitate the illegal online sale of drugs.

Baney, who is also senior advisor to the Alliance for Safe Online Pharmacies (ASOP Global), said that the organization “strongly endorses the act…The bill’s requirement for registrars and registries to lock offending domain names within 24 hours of notification from a trusted notifier and suspend them within seven days would provide powerful new protections to keep consumers safe online.” She added, “The introduction of the act marks a major milestone in the fight against illegal online drug sales, and ASOP Global urges its swift passage in Congress.”

The full article is available for World Trademark Review subscribers.